 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Abstract and Travel Grant submission has been closed.
Thank you for applying many abstracts.
Thank you for applying many abstracts.
Abstract and Travel Grant Submission Guidelines
These guidelines are limited to non-Japanese ophthalmologists living outside of Japan who would like to submit abstracts as “international members”.
Non-Japanese ophthalmologists residing in Japan or who belong to a Japanese institution should become members of the Japanese Ophthalmological Society and submit their abstract on the Japanese site.
Current members of the Japanese Ophthalmological Society should also submit their abstract on the Japanese site.
Submissions are accepted only via e-mail to the Conference Secretariat (
) by filling out the Abstract Submission Form attached at the bottom of this page.
Non-Japanese ophthalmologists residing in Japan or who belong to a Japanese institution should become members of the Japanese Ophthalmological Society and submit their abstract on the Japanese site.
Current members of the Japanese Ophthalmological Society should also submit their abstract on the Japanese site.
Submissions are accepted only via e-mail to the Conference Secretariat (
) by filling out the Abstract Submission Form attached at the bottom of this page. Submission Dates and Deadline
Oral and Poster Presentation submissions will be accepted from September 27 (Tue) to November 10 (Thu), 2011, 12:00 noon (Japan Time). Late submissions will not be considered.
Submission Deadline November 10 (Thu), 2011, 12:00 (Japan Time)
Application for General Presentation (Oral/Poster)
1. Select the style of presentation
2. Select an appropriate category from the following list
| Oral Presentation: | |
| Digital Presentation only (film slides or videotapes are not allowed) | |
| Poster Presentation: | |
| Discussion in the Poster/Exhibition Hall | |
2. Select an appropriate category from the following list
| 01 | Keratoconjunctivitis | 06 | Strabismus, Amblyopia, Pediatric Ophthalmology, Neuro-Ophthalmology | ||
| 02 | Crystalline Lens, Cataract | 07 | Refraction, Visual Function | ||
| 03 | Glaucoma | 08 | Tumor, Orbit, Eyelid, Lacrimal Functional Unit, Pathology, Pharmacology | ||
| 04 | Retina, Vitreous Body | 09 | Low Vision, Color Vision, Electrophysiology |
||
| 05 | Ocular Inflammation, Infection, Uvea |
10 | Medical Services, Medical Politics, Others |
Applicants' Qualification
The first author (presenter) of a general presentation should be an international member of the Japanese Ophthalmological Society. Non-members at the time of application are eligible to submit an application and will be granted an international membership after acceptance of abstract, endorsement from the presidents and approval by the Board. For further information on international membership, please review here.
Guidelines for Abstract Preparation
| 1. | Papers that have been or will be presented in other academic meetings in Japan or that have already been published in Japan cannot be accepted. |
| 2. | A presenter may make only one general presentation, as the first author. |
| 3. | The title should be no longer than 80 characters including spaces, affiliation should be concise and the abstract no longer than 1200 characters including spaces. Short title should be no longer than 40 characters including spaces. |
| 4. | The abstract should be structured with the Headings, Objective, Subjects and Methods, Results, and Conclusions, in that order. For case reports and invention or improvement of techniques and devices, the Headings should be appropriately changed (for example, for case reports, Introduction, Cases, Discussion and, if relevant, Conclusions). |
| 5. | Methods, Results, etc. should be described clearly, with numerical values and the statistical analysis methods used, where possible. Invention or improvement of techniques and devices should also be described clearly. |
| 6. | The Conclusion and Discussion should conform to the Results described. |
| 7. | Common names should be used for chemicals. Trade names should be given (……®) after the common names, if necessary (Example: timolol maleate [Timoptol®]). |
| 8. | Presentations, abstracts and presentation data must be prepared in English. |
| 9. | See below for declaration of conflict of interests. |
| 10. | On the Abstract Submission Form under Approval of the Ethics Committee, please check the box for whether you have obtained an approval of the ethics committee, e.g. IRB, or if it is not necessary. This does not need to be stated in the abstract text. |
| 11. | On the Abstract Submission Form under Informed Consent, please check the box for whether you have obtained an informed consent or if it is not necessary. This does not need to be stated in the abstract text. |
Appendix
| 1. | When duplicate submission (presentation) is suspected, ask the Committee for Judging Duplicate Presentations of the Japanese Ophthalmological Society in advance. |
| 2. | When duplicate submission (presentation) is revealed after the registration deadline, presentations by the author (presenter) and co-authors (co-presenters) of the abstract may be temporarily suspended. In addition, their names may also be published in the Japanese Journal of Ophthalmology. |
| 3. | The content of the abstract and its description are similarly evaluated by peer review, and revisions are not allowed after the registration deadline. |
| 4. | At the Annual Congress of Japan Clinical Ophthalmology, presentations are given on clinical research and basic research related to the clinical relevance, and those on pure basic research are not accepted. At the Annual Meeting of the Japanese Ophthalmological Society, presentations are given mainly on basic research, but those on clinical research are also acceptable. |
| 5. | When the presentation includes part of the research conducted by multiple institutions, agreement of the persons concerned should be obtained, and the content of the agreement should be described in the Abstract. |
| 6. | Meaningless rhetoric, prefixes (for example, Mr., Ms., Prof. and Dr.) inappropriate for academic papers, should not be used. |
| 7. | Abstracts without data in the Results section, such as those that only state “will be investigated” and “we describe…,” may be rejected. |
| 8. | Conclusions should not be drawn from any content(s) not described in the Results. |
| 9. | The number of authors is not limited. However, if the number is 13 or more, the conference secretariat must be informed. |
| 10. | Withdrawal and revision after the registration deadline are not allowed under any circumstances. *Please note that if a presenter does not attend and make a presentation at the designated time and place without prior notice, as a penalty the presenter will not be allowed to make a presentation as the first presenter in the next meeting. This policy was laid down by the Program Committee of the Japanese Ophthalmological Society. If unable to attend the meeting for any compelling reason on the designated day and time, the presenter must inform the conference secretariat promptly and submit a statement of reasons for absence to the conference secretariat by letter or e-mail by the end of the meeting. |
The 116th Annual Meeting of the Japanese Ophthalmological Society
Conference Secretariat
Conference Secretariat
 |
(Open hours: 10:00 to 18:00; closed on Saturdays, Sundays and National Holidays)
4-1-12-203 Minami-Aoyama, Minato-ku, Tokyo 107-0062TEL: +81-3-3-5775-2075 FAX: +81-3-5775-2076
Conflict of Interest
When making a presentation at the Annual Meeting of the Japanese Ophthalmological Society and the Annual Congress of Japan Clinical Ophthalmology, the authors have to report any conflict of interest using the prescribed format of the Japanese Ophthalmological Society through the meeting secretariat, based on “the rules for conflict of interest of JOS.” If the presentation is accepted, the category of conflict of interest and company names will be disclosed in the Abstract and in the slide and poster for presentation, based on “the rules for disclosure of JOS.”
Presentations to which these rules are applicable
These rules are applicable to all presentations, including those in Co-Sponsored Seminars, Special Lectures, Invited Lectures, Board of Councilors Nominated Lectures, Symposia (including the ARVO-JOS Symposium), Educational Seminars, Subspecialty Sunday, Academic Award Memorial Lectures, Skill Transfer, General presentations (including posters), etc., are included.
Report on Conflict of Interest
Report the present or absent of conflict of interest with companies related to the presentation at this meeting. Select the present or absent of conflict of interest on the “Abstract Submission Form.” If conflict of interest is “present,” enter the category and company names in the “report on conflict of interest” on the form. If conflict of interest is absent, select “category N.” Confirm the declaration is correct prior to the registration. By checking that the declaration is correct, the declaration will be considered as signed. Categories and classes are as follows.
1. Category
| F (Financial Support): | ||
| In the case where research expenses are supported or free research materials (including devices) or services (including sample measurements) are provided by companies (*) through the organization to which the author belongs for research relevant to the presentation at this meeting (*) Companies denote both related companies and competitor companies. This is also the case for all subsequent categories. |
||
| I (Personal Financial Interest): | ||
| In the case where the author is an investor in a company related to the chemicals and materials (including devices) used and services are provided for research relevant to the presentation at this meeting | ||
| E (Employee): | ||
| In the case where the author is an employee of an interested company concerning the presentation at this meeting | ||
| C (Consultant): | ||
| In the case where the author is currently, or was within the past three years, a consultant of an interested company concerning the presentation at this meeting | ||
| P (Patent): | ||
| In the case where the author is related to (1) inventors/developers, patent applications or copyrights that may conflict with the contents and technologies presented at this meeting, or is related to (2) licenses or commercialization although not related to non-disclosure agreements, patents, copyrights, etc. | ||
| R (Rewards): | ||
| In the case where the author receives rewards (*) or travel expenses from a company related to the chemicals and materials (including devices) used and services provided for research related to the presentation at this meeting (*) Rewards include salaries, travel fees, intellectual property rights, royalties, honoraria, shares, stock options, consultancy fees, lecture fees, expenses of members of advisory committees and review panels, etc. |
||
| N (No Commercial Relationship): | ||
| In the case where the author has no conflict of interest with any company concerning the presentation at this meeting | ||
2. Class
| I. | 0 yen | |
| II. | From 1 to less than 500,000 yen | |
| III. | From 500,000 to 5,000,000 yen | |
| IV. | Over 5,000,000 yen |
| * | Conflict of interest should be disclosed for the fiscal year during the previous three years when the author received the largest sum of money. |
Disclosure in the Abstract and Slide
1. Abstract:
The present or absent of conflict of interest for the author (including co-authors) and, if conflict of interest is present, the category and company names, will be automatically shown at the end of the abstract, according to “the detailed rules of the standard for disclosure in the Japanese Ophthalmological Society.” For categories F, C and R, only class IV (over 5,000,000 yen) will be disclosed.
2. Slide and poster:
If the authors have to disclose any conflict of interest, the category and company names should be described after the authors' names in the second slide and at the end of the poster, as shown in the example below. For categories F, C and R, only class IV (over 5,000,000 yen) should be disclosed.
If all authors do not have any conflict of interest to disclose, there will be a statement to the effect, “there is no conflict of interest to be disclosed”.
- Slide Example (PowerPoint / PDF) -
Thank you for your cooperation. Please contact the conference secretariat for any questions by e-mail or FAX (not by telephone).
Thank you for your cooperation. Please contact the conference secretariat for any questions by e-mail or FAX (not by telephone).
Conference Secretariat Mediproduce Inc.
|
Fax: +81-3-5775-2076 |
Personal Information Protection
“Names” and “contact addresses” provided to us at registration for the meeting shall be for contact from the secretariat, notification of acceptance or rejection, and any information related to the presentation. In addition, the “presenters' names,” “affiliation names,” “title” and “abstract text” shall be used for publishing in the program/proceedings and on the website, but not for other purposes. The operation of registering applications has been commissioned to the Congress Corporation for smooth conduct of the management operations.
Notification of Receipt of Abstracts
For registration confirmation, notification will be sent to the registered e-mail address. If you do not receive notification at the registered e-mail address within 7 days, please inform the conference secretariat. For submissions (general presentations), notification of acceptance or rejection will be sent to the registered e-mail address around mid-January 2012 (planned).
Payment of 1) The International Membership fee for JOS and 2) The registration fee for the 116th JOS not completed by the end of January will be considered as a withdrawal your abstract. We will inform you of the payment details on our notification email.
Payment of 1) The International Membership fee for JOS and 2) The registration fee for the 116th JOS not completed by the end of January will be considered as a withdrawal your abstract. We will inform you of the payment details on our notification email.
Travel Grant
The 116th Annual Meeting of the Japanese Ophthalmological Society offers Travel Grants to non-Japanese overseas ophthalmologists who would like to submit abstracts as international members, traveling mainly from Asia and Oceania to present high quality papers at the meeting.
Only one person per abstract (the presenting author) will be considered for the Travel Grant. Funding for travel will depend on the travel distance and not exceed $1,000 USD per grant, and will be limited to 30 to 50 winners.
After completing the abstract submission form and checking the box for “Applying for Travel Grant,” please send the form to the Congress Secretariat () to complete your application.
Please note that applications for the Travel Grant will be accepted from September 27 (Tue) to November 10 (Thu), 2011, 12:00 pm. Decisions for Travel Grant awards will be made by mid− January, at the same time as notification of abstract acceptance. All winners need to complete the payment of 1) the International Membership of JOS and 2) the registration fee for the 116th JOS by the end of January, We will inform you of the payment details in our notification email.
Only one person per abstract (the presenting author) will be considered for the Travel Grant. Funding for travel will depend on the travel distance and not exceed $1,000 USD per grant, and will be limited to 30 to 50 winners.
After completing the abstract submission form and checking the box for “Applying for Travel Grant,” please send the form to the Congress Secretariat (
) to complete your application.Please note that applications for the Travel Grant will be accepted from September 27 (Tue) to November 10 (Thu), 2011, 12:00 pm. Decisions for Travel Grant awards will be made by mid− January, at the same time as notification of abstract acceptance. All winners need to complete the payment of 1) the International Membership of JOS and 2) the registration fee for the 116th JOS by the end of January, We will inform you of the payment details in our notification email.
To Apply for a Travel Grant
Step 1. Abstract Submission
All Travel Grant applicants need to submit the abstracts instructed above using the attached form. Only one form is necessary when submitting an abstract and applying for a Travel Grant.
Step 2. Travel Grant Application
Submit an abstract and apply for a Travel Grant at the same time.
A publication list is required in addition to the abstract application documents.
Step 3. Application
Send the completed form to the Congress Secretariat () by November 10 (Thu), 2011, 12:00 pm for application. Submissions are accepted only via e-mail to the Conference Secretariat by filling out the Abstract Submission Form attached at the bottom of this page.
All Travel Grant applicants need to submit the abstracts instructed above using the attached form. Only one form is necessary when submitting an abstract and applying for a Travel Grant.
Step 2. Travel Grant Application
Submit an abstract and apply for a Travel Grant at the same time.
A publication list is required in addition to the abstract application documents.
Step 3. Application
Send the completed form to the Congress Secretariat (
) by November 10 (Thu), 2011, 12:00 pm for application. Submissions are accepted only via e-mail to the Conference Secretariat by filling out the Abstract Submission Form attached at the bottom of this page.
Inquiry about registration methods
The 116th Annual Meeting of the Japanese Ophthalmological SocietyConference Secretariat
(Open hours: 10:00 to 18:00; closed on Saturdays, Sundays and National Holidays)
4-1-12-203 Minami-Aoyama, Minato-ku, Tokyo 107-0062TEL: +81-3-3-5775-2075 FAX: +81-3-5775-2076
|
 |
